...
首页> 外文期刊>International journal of clinical oncology >Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
【24h】

Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer

机译:S-1,奥沙利铂和贝伐单抗联合放疗的新辅助术前化疗在局部晚期直肠癌患者中的I期试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This phase I study was performed to determine the maximum tolerated dose (MTD), recommended dose (RD), and dose-limiting toxicities (DLTs) of oxaliplatin combined with preoperative chemoradiotherapy with S-1, oxaliplatin, and bevacizumab in locally advanced rectal cancer.
机译:这项I期研究旨在确定奥沙利铂联合术前放化疗联合S-1,奥沙利铂和贝伐单抗在局部晚期直肠癌中的最大耐受剂量(MTD),推荐剂量(RD)和剂量限制毒性(DLT) 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号